Episode Summary
In this episode of ‘Conversations in Lung Cancer Research,’ hosted by A/Prof Mal Itchins, a multidisciplinary panel delves into the ongoing advancements in lung cancer research in Australia and New Zealand. The panel includes Prof Nick Pavlakis from Royal North Shore Hospital and A/Prof Lauren Troy from Royal Prince Alfred Sydney. Key topics discussed include the National Lung Cancer Screening Program (NLCSP), anticipated pharmaceutical benefits scheme (PBS) drug listings for 2026, and the introduction of advanced diagnostic technologies. The conversation highlights the initial impacts of the lung cancer screening program, potential benefits of new ALK inhibitors, and the expanding role of immunotherapy. This episode also explores the future of diagnostic precision with the rise of interventional pulmonology and liquid biopsies. Additionally, it emphasises the growing importance of specialised lung cancer nursing and the integration of novel technologies in oncology practices.
*This episode was recorded prior to the PBS update in December 2025.
Show Guests
- A/Prof Lauren Troy, Senior Staff Specialist in Respiratory Medicine, Royal Prince Alfred Hospital
- Prof Nick Pavlakis, Senior Staff Specialist in the Department of Medical Oncology, Royal North Shore Hospital
- A/Prof Malinda Itchins, Medical Oncologist and Clinician
Researcher, Chris O’Brien Lifehouse and Royal North Shore Hospital
